Renal/Urology · PANCE / PANRE

Acute Cystitis (Uncomplicated UTI)

Lower urinary tract infection in non-pregnant, immunocompetent woman with normal anatomy.

Also known as: acute cystitis, uncomplicated UTI, lower UTI, bladder infection

Overview

Inflammation and infection of the bladder mucosa, typically caused by ascending bacterial infection. 'Uncomplicated' refers to cystitis in non-pregnant, premenopausal women with no functional or structural urinary tract abnormality and no relevant comorbidities. All other cases (men, pregnancy, catheter, anatomic abnormality, immunocompromise, pyelonephritis) are 'complicated.'

Epidemiology

Among the most common bacterial infections — ~50% of women experience at least one UTI in their lifetime. Peak incidence in sexually active women aged 18-30 and postmenopausal women. Rare in healthy men under 50.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Cystitis (Uncomplicated UTI) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Female anatomy (short urethra, proximity to perineum)
  • Sexual activity, new partner, spermicide/diaphragm use
  • Postmenopausal estrogen deficiency (vaginal atrophy)
  • History of recurrent UTI
  • Diabetes mellitus, immunocompromise
  • Anatomic abnormalities, neurogenic bladder, indwelling catheter, recent instrumentation

Pathophysiology

Uropathogens (most commonly uropathogenic E. coli, ~80%) ascend from the urethra into the bladder. Bacterial adhesins (fimbriae) attach to uroepithelial cells; invasion triggers inflammatory response with neutrophil infiltration. Symptoms reflect bladder mucosal irritation rather than systemic illness.

Clinical presentation

Symptoms

  • Dysuria (burning with urination)
  • Urinary frequency, urgency
  • Suprapubic pain or discomfort
  • Cloudy or malodorous urine; sometimes gross hematuria
  • Absence of fever, flank pain, or systemic symptoms (presence suggests pyelonephritis)

Signs / physical exam

  • Often unremarkable exam
  • Mild suprapubic tenderness on palpation
  • Absence of CVA tenderness, fever, or hemodynamic compromise
  • Pelvic exam if vaginitis or STI suspected

Classic findings

Sexually active young woman with sudden dysuria, frequency, and urgency without vaginal discharge or fever — empiric treatment without urine culture is reasonable.

Differential diagnosis

  • Acute pyelonephritis — Fever, flank pain, CVA tenderness, systemic symptoms — upper tract involvement requires different treatment
  • Urethritis (STI) — Gonorrhea, chlamydia, trichomonas; sexually active patient, partner symptoms, sterile pyuria with negative routine culture
  • Vaginitis — Vaginal discharge, pruritus, dyspareunia; positive wet prep, KOH, or whiff test
  • Interstitial cystitis — Chronic pelvic pain, urinary frequency without infection, negative cultures
  • Overactive bladder — Frequency, urgency without infection; positive bladder diary
  • Bladder cancer — Older patients (smokers), painless gross hematuria, recurrent 'UTI' with negative culture

Diagnostic workup

Diagnostic criteria

Clinical diagnosis based on symptoms (dysuria, frequency, urgency, suprapubic pain) supported by pyuria. Urine culture with ≥10^5 CFU/mL (or ≥10^3 CFU/mL with symptoms) confirms but is often not necessary for treatment initiation in classic cases.

Labs

  • Urinalysis (dipstick or microscopy) — pyuria (>10 WBCs/HPF or positive leukocyte esterase), bacteriuria, nitrites (gram-negative bacteria reduce nitrate to nitrite)
  • Urine culture — not required in uncomplicated cystitis with classic symptoms but recommended in: recurrent UTI, treatment failure, complicated UTI, pregnancy, men, suspected pyelonephritis
  • Beta-hCG in women of reproductive age if treatment selection or pyelonephritis concern
  • STI testing (NAAT for GC/CT) if sexually active and risk factors

Imaging

  • Not required for uncomplicated cystitis
  • Imaging (US or CT) considered for recurrent, complicated, or treatment-resistant UTI to evaluate for stones, abscess, anatomic abnormality

Diagnostic algorithm

AntibioticDose / DurationNotes / Cautions
Nitrofurantoin100 mg PO BID × 5 daysAvoid if eGFR <30, pyelonephritis suspected, near term pregnancy
TMP-SMX1 DS tab PO BID × 3 daysAvoid if local resistance >20% or prior 3-month use; avoid in 1st trimester and near term
Fosfomycin3 g PO × 1 doseSingle dose; less effective than 5-day regimens
Cephalexin500 mg PO BID × 5-7 daysSecond-line; safe in pregnancy
Amoxicillin-clavulanate500 mg PO BID × 5-7 daysSecond-line; safe in pregnancy
FluoroquinolonesReserve for pyelonephritis or complicated UTIFDA black box for uncomplicated cystitis
IDSA-recommended antimicrobial regimens for acute uncomplicated cystitis in adult women.

Treatment

First-line

  • Nitrofurantoin monohydrate/macrocrystals 100 mg PO BID × 5 days (avoid if eGFR <30 or pyelonephritis suspected)
  • Trimethoprim-sulfamethoxazole (TMP-SMX) DS PO BID × 3 days — use only if local resistance <20% and patient not exposed in prior 3 months
  • Fosfomycin 3 g PO × 1 dose — convenient single dose; less effective than 5-day regimens
  • Avoid fluoroquinolones for uncomplicated cystitis (FDA black box; reserve for complicated UTI/pyelo)
  • Symptomatic relief: phenazopyridine (Pyridium) for dysuria — ≤2 days, warn about orange urine; avoid in G6PD deficiency

Second-line / adjunct

  • Beta-lactams (amoxicillin-clavulanate, cefpodoxime, cefdinir) — second-line; less effective than first-line agents
  • For recurrent UTI: postcoital prophylaxis, continuous low-dose prophylaxis (nitrofurantoin, TMP-SMX), or self-start therapy
  • Postmenopausal women: vaginal estrogen for recurrent UTI (reduces frequency)
  • Cranberry products — modest evidence; not a replacement for antibiotics in acute UTI
  • Pregnancy: cephalexin, amoxicillin-clavulanate, nitrofurantoin (NOT in 1st trimester or near term), or fosfomycin; AVOID TMP-SMX in 1st trimester and near term; AVOID fluoroquinolones

Complications

  • Progression to pyelonephritis if untreated or treatment failure
  • Recurrent UTI (re-infection or relapse)
  • Pregnancy: untreated UTI increases risk of pyelonephritis (up to 30%), preterm labor, low birth weight
  • Antibiotic-associated complications: C. difficile colitis, allergic reactions, antimicrobial resistance
  • Rare: bacteremia/urosepsis in compromised hosts

PANCE pearls

  • Classic dysuria + frequency in a young healthy woman without vaginal symptoms can be treated empirically without urinalysis or culture (per IDSA).
  • Nitrites positive = gram-negative organism reducing nitrate; absence does NOT exclude UTI (gram-positives like Staph saprophyticus and Enterococcus don't produce nitrites).
  • Asymptomatic bacteriuria should be treated ONLY in: pregnancy and before urologic procedures with mucosal trauma. Do NOT treat asymptomatic bacteriuria in elderly, diabetics, catheter, or general population.
  • Pyuria without bacteriuria (sterile pyuria) = consider urethritis (STI), TB, interstitial cystitis, or partially treated UTI.
  • In men, any UTI is considered complicated and warrants culture, longer treatment (7-14 days), and evaluation for underlying cause (BPH, prostatitis, stones).

References

  • IDSA 2011 — International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis (Gupta et al., CID 2011)
  • AUA/CUA/SUFU 2022 — Recurrent Uncomplicated UTI in Women: AUA/CUA/SUFU Guideline (Anger et al., J Urol 2022)
  • USPSTF 2019 — Screening for Asymptomatic Bacteriuria in Adults: USPSTF Recommendation Statement (Owens et al., JAMA 2019)

Practice Renal/Urology questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.